
Ovesse, a vaginal oestrogen cream, has become the first of its kind available over-the-counter in the UK offering new possibilities for millions of postmenopausal women suffering from vaginal atrophy, a condition affecting approximately 50% of women after menopause.
Ovesse is a prescription-strength vaginal cream containing estriol, a naturally occurring oestrogen hormone. It’s designed to treat vaginal atrophy by replacing the oestrogen no longer produced by the ovaries post-menopause. The cream is applied directly to the vagina using a reusable applicator, providing localized treatment where it’s needed most.
The availability of Ovesse without a prescription marks a significant shift in women’s healthcare. Postmenopausal women can now access this treatment directly from Boots pharmacies, both in-store and online. This increased accessibility may empower women to address their symptoms more readily, potentially improving their quality of life and intimate relationships.
Ovesse follows a two-phase treatment process:
- Initial phase: One application daily for two weeks
- Maintenance phase: One application twice weekly
This regimen allows for effective symptom management while minimizing hormone exposure.
Nicholas Scott, Head of Northern Europe Commercial at Aspen Pharmacare commented: “We’re delighted to be launching Ovesse vaginal cream into the UK, as a non-prescription option for postmenopausal women experiencing symptoms of vaginal atrophy. We know that speaking to a doctor or getting a prescription can sometimes deter women from seeking help. Ovesse will help improve access to this healthcare product and help empower postmenopausal women experiencing vaginal atrophy symptoms to manage their health with greater ease and confidence.”
The introduction of over-the-counter Ovesse reflects a growing recognition of the importance of menopause-related health issues. It provides an additional tool for women to manage their health proactively, potentially reducing the stigma associated with discussing these symptoms. However, it’s crucial to remember that while Ovesse offers a valuable treatment option, it’s not a one-size-fits-all solution.
As we move forward, this development may pave the way for more accessible treatments for menopausal symptoms, furthering the conversation around women’s health and empowering women to take control of their well-being during this significant life transition.